Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women
Clinical trial NCT06315205 · COMPLETED
Trial details
- NCT number
- NCT06315205
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-26
- Primary completion
- 2026-03-11
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.